Related Experiment Video
Updated: Oct 21, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after
Euihong Ko1, Do-Yoon Kang1, Jung-Min Ahn1
1Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
Insights
Higher valvular/subvalvular calcium burden in transcatheter aortic valve replacement (TAVR) patients correlated with increased paravalvular leakage and pacemaker needs. However, adjusted long-term composite outcomes and mortality risks were not significantly affected by calcium levels.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Imaging
Background:
- Severe aortic stenosis (AS) necessitates intervention, with transcatheter aortic valve replacement (TAVR) being a primary treatment.
- Valvular and subvalvular calcification are common in AS patients undergoing TAVR.
- The prognostic impact of baseline calcium burden on TAVR outcomes requires further elucidation.
Purpose of the Study:
- To evaluate the association between valvular/subvalvular calcium burden and procedural/long-term outcomes following TAVR.
- To stratify patients based on calcium volume tertiles and assess their clinical trajectories.
Main Methods:
- Prospective observational cohort study of 676 AS patients undergoing TAVR (March 2010-December 2019).
- Baseline calcium burden quantified via multidetector computed tomography and categorized into tertiles.
- Procedural outcomes (paravalvular leakage, permanent pacemaker insertion) and 12-month clinical outcomes (composite of death, stroke, rehospitalization; all-cause mortality) were analyzed.
Main Results:
- Moderate/severe paravalvular leakage and permanent pacemaker insertion rates increased proportionally with higher calcium tertiles (P-for-trend < 0.05).
- The 12-month composite outcome rate was significantly different across tertiles (log-rank P = 0.02), but multivariable analysis showed no significant difference in adjusted risks (middle-tertile HR 0.81; high-tertile HR 0.93).
- All-cause mortality followed a similar pattern, with no significant adjusted differences between calcium groups.
Conclusions:
- While increased valvular/subvalvular calcium burden is associated with higher rates of procedural complications like paravalvular leakage and permanent pacemaker insertion, it does not appear to significantly impact adjusted 12-month composite outcomes or all-cause mortality after TAVR.
- Calcium burden assessment may inform procedural risk stratification but does not appear to be an independent predictor of long-term adverse events in this cohort.
Aims:
This study aimed to assess the impact of valvular/subvalvular calcium burden on procedural and long-term outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS).
Methods And Results:
In this prospective observational cohort study, we included patients with AS undergoing TAVR between March 2010 and December 2019. Calcium burden at baseline was quantified using multidetector computed tomography and the patients were classified into tertile groups according to the amount of calcium. Procedural outcomes [paravalvular leakage (PVL) or permanent pacemaker insertion (PPI)] and 12-month clinical outcomes (composite of death, stroke, or rehospitalization, and all-cause mortality) were assessed. A total of 676 patients (age, 79.8 ± 5.4 years) were analysed. The 30-day rates of moderate or severe PVL (P-for-trend = 0.03) and PPI (P-for-trend = 0.002) proportionally increased with the tertile levels of calcium volume. The 12-month rate of primary composite outcomes was 34.2% in low-tertile, 23.9% in middle-tertile, and 25.8% in high-tertile groups (log-rank P = 0.02). After multivariable adjustment, the risk for primary composite outcomes at 12 months was not significantly different between the tertile groups of calcium volume [reference = low-tertile; middle-tertile, hazard ratio (HR) 0.81; 95% confidence interval (CI) 0.54-1.22; P = 0.31; high-tertile, HR 0.93; 95% CI 0.56-1.57; P = 0.80]. A similar pattern was observed for all-cause mortality.
Conclusion:
The rates of PVL and PPI proportionally increased according to the levels of valvular/subvalvular calcium volume, while the adjusted risks for composite outcomes and mortality at 12 months were not significantly different.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests

